Evidence map›Paper›PMID 34204432›Full record

ArticleInternational journal of molecular sciences2021

MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway.

Beatriz Ballester, Javier Milara, Paula Montero, Julio Cortijo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Revealing the impact ofFrontiers in immunology · 2025
    Article
  10. Review
  11. Article
  12. MUC16: clinical targets with great potential.Clinical and experimental medicine · 2024
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Beatriz BallesterComprehensive Pneumology Center (CPC), Helmholtz Zentrum München, 85764 Munich, Germany.ORCID 0000-0003-3059-6426
Javier MilaraCIBERES, Health Institute Carlos III, 46010 Valencia, Spain.
Paula MonteroDepartment of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Julio CortijoCIBERES, Health Institute Carlos III, 46010 Valencia, Spain.
Universitat de València · ESInstituto de Salud Carlos III · ES

Funding

Alexander von Humboldt-Stiftung Postdoctoral fellowshipCentro de Investigación Biomédica en red sobre enfermedades respiratorias CB06/06/0027Conselleria d'Educació, Investigació, Cultura i Esport Prometeo 2017/023/UVInstituto de Salud Carlos III FIS PI20/01363Ministerio de Ciencia, Innovación y Universidades SAF2017-82913-R
6 · The paper itself

Abstract

Several transmembrane mucins have demonstrated that they contribute intracellularly to induce fibrotic processes. The extracellular domain of MUC16 is considered as a biomarker for disease progression and death in IPF patients. However, there is no evidence regarding the signalling capabilities of MUC16 that contribute to IPF development. Here, we demonstrate that MUC16 was overexpressed in the lung tissue of IPF patients (

Indexed as

Gene ExpressionSignal TransductionAgedBiomarkersCA-125 AntigenCase-Control StudiesCell LineCell ProliferationDisease SusceptibilityFemaleFibroblastsHumansIdiopathic Pulmonary FibrosisImmunohistochemistryLungMaleBiomarkersCA-125 AntigenMembrane ProteinsMUC16 protein, humanTransforming Growth Factor beta1idiopathic pulmonary fibrosisMUC16transforming growth factor beta

Identifiers

PMID34204432
PMCPMC8235375
OpenAlexW3168337236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.